PE4S283 - Personalised Diabetes Management - Pharmacology 19 Sep 2024 - 31 Aug 2031 | Version 5
Associated Module Information
| Module Code: | PE4S283 | ||
|---|---|---|---|
| Module Title: | Personalised Diabetes Management - Pharmacology | ||
| Faculty: | Faculty of Life Sciences and Education | ||
| Faculty Group: | Allied Health and Chiropractic | ||
| Faculty Sub Group: | Clinical Services | ||
| Module Leader: | Karl New | ||
| Module Team: | |||
| First Intended Intake: | MAR 2025 | Final Year of Intake: | 2030 |
| Date Closed: | |||
| Credit Value: | 20 | Credit Level: | 7 |
| Language: | English | ||
| Percentage of Module Taught in Welsh: | 0 | ||
| Equivalent Module: | |||
| HECOS codes: | 100260 - healthcare science | ||
| HECOS Code Weighting: | 100 | ||
Document Version Information
| Version | 5 |
|---|---|
| Valid From | 19 Sep 2024 |
| Valid To | 31 Aug 2031 |
Module Aims
To critically analyse the evolving landscape of pharmacological interventions in diabetes management, shifting towards a comprehensive approach emphasising cardio-renal-metabolic control and protection, and equip students with knowledge of emerging therapeutic horizons beyond glycemic control.
Content Summary
Indicative content to include topics outlined below and/or any other relevant current topics to fulfil the module aims and learning outcomes:
Topics may include:
Oral medications in the management of T2DM
Non-Insulin injectables
Pivotal studies
Insulin based therapies
Learning and Teaching Methods
| Activity Type | Hours |
|---|---|
| Seminars | 40 |
| Independent Study | 80 |
| Direct Study (including online independent learning) | 40 |
| Problem/Challenge-based Learning | 40 |
| Total Hours Selected | 200 |
Learning Outcomes
| # | Learning Outcome |
|---|---|
| LO1 | Synthesise knowledge of the mechanisms of action, evidence base, and clinical applications of pharmacological interventions for type 2 diabetes, with a focus on cardio-renal protection. |
| LO2 | Integrate practical considerations and emerging approaches in insulin-based therapies for effective management of type 1 and type 2 diabetes. |
Module Requisites
N/A
Assessment Criteria
| Assessment Category | Assessment Type | Description | Duration | Word Count | Weight (%) | Best of? | Pass Mark |
|---|---|---|---|---|---|---|---|
| Asynchronous Assessment | Case study 1 | A concentrated inquiry into a single case or subject. Learna: Case-based scenarios and a discussion forum related to Personalised Diabetes Management. | 0 | 2500 | 40 | No | 40 |
| Asynchronous Assessment | Project 1 | A detailed analysis of a topic, involving some original research undertaken by the candidate who makes use of data and/or primary sources. Learna: Completion of an individual/group task related to Personalised Diabetes Management | 0 | 1000 | 20 | No | 40 |
| Asynchronous Assessment | Self Reflective Assessment 1 | A personal record of a student’s learning experiences. It requires students to record and reflect upon their observations and responses to situations, which can then be used later to explore and analyse ways of thinking and being in context. Generally involves critical diaries, learning logs and written / visual journals. Learna: Reflective journal. | 0 | 600 | 10 | No | 40 |
| Synchronous Online Assessment | Time-constrained assessment (Online) 1 | Assessment to be completed in a specific timescale, which is neither an invigilated examination nor a piece of coursework. To be completed over an extended period (e.g. a 2-hour task to be completed within 48 hours, or a 24-hour assessment). Learna: End of module 1-hour Case-based Multiple-choice Examination related to Personalised Diabetes Management to be completed within a 10-day period. | 60 | N/A | 30 | No | 40 |
Assessment Matrix
| Assessment Type | Learning Outcomes | ||
|---|---|---|---|
| LO1 | LO2 | ||
| Case study 1 | ✔ | ✔ | |
| Project 1 | ✔ | ✔ | |
| Self Reflective Assessment 1 | ✔ | ✔ | |
| Time-constrained assessment (Online) 1 | ✔ | ✔ | |